Sven Kili work email
- Valid
- Valid
- Valid
- Valid
- Valid
Sven Kili personal email
- Valid
An experienced Cell & Gene Therapy Senior Leader and Board Member with a strong track record of leadership and teamwork in developing and commercialising innovative advanced therapies. My focus is on delivering positive ethical outcomes for patients and customers by utilising a commercially-minded and pragmatic approach to advanced therapy development. As a pharmaceutical physician and clinician I have extensive surgical and medical clinical experience with a strong patient focus.Additional Positions:Xintela AB (Sweden) - Board Member and Interim CMO & COOCCRM (Canada) - Board Member and Investment Committee memberBIA Cell & Gene Advisory Committee ChairStandards Coordinating Body - Executive Board MemberSenior Medical and business strategic expertise focussed on extensive Clinical Development and Medical Affairs expereince involving a broad range of activities including: Ethical promotion of Medicines and Devices (UK, EU, US, Asia, Australia); Clinical research (phase II/ III/ IV) and product registration and reimbursement activities.Therapy area Expertise:Cell Based Therapies, including Gene Therapies and Gene Modified cellsStem CellsCartilage repair and regenerationJoint resurfacingBone repair and growthRare DiseasesRenal Medicine (CKD- pre and dialysis)Cardiovascular medicine (Familial Hypercholesterolemia)Medical devicesSurgical disciplines (Orthopaedics, Reconstructive surgery, Urology, GI Surgery, Neurosurgery, Vascular surgery, Cardiothoracic surgery)Specialties: Biotech business company formation, management and strategyMedical AffairsResearch and Development Drugs safety, Device Safety and pharmacovigilance - (EU QPPV experience)Regulatory Strategies for medicines and ATMP productsProduct aquisition and due diligence activitiesPractical training (internal and external)EU licence application activities (MAA CTD, RMP and PiP)Risk & crisis management and communicationMarket access planning (NICE, SMC, AWMSG)
-
PartnerSaisei VenturesUnited Kingdom
-
Chief Development OfficerCcrm Jan 2024 - PresentToronto, Ontario, Ca -
Member Of The BoardCcrm Jan 2017 - Jan 2024Toronto, Ontario, CaCCRM is a not-for-profit, public-private consortium supporting the development of foundational technologies that accelerate the commercialization of cell and gene therapies, and regenerative medicine technologies.Cell and gene therapies, and regenerative medicine-based products and therapies have the potential to transform health care, with the promise to treat, manage and perhaps cure some of the most debilitating and costly diseases in the world today. However, many new potentially life-changing cell, gene and regenerative medicine-based treatments never reach patients because they are not successfully moved from the laboratory to the clinic.Canadian scientific excellence in stem cells, bioengineering and biomaterials combined with existing infrastructure positions CCRM to coordinate product development and commercialization in a capital-efficient manner.
-
Investment AdvisorSaisei Ventures Sep 2023 - PresentCambridge, UsBoutique VC firm investing in transformative science and exceptional people to build great cell and gene therapy companies. We combine the best from Japan and The United States & Europe.
-
PrincipalSven Kili Consulting Ltd Jul 2018 - PresentI support Small and Medium-sized CGT and Regen Med companies to grow thoughtfully and optimise their Strategy, capabilities and Product Development with an unwavering focus on the patient.Areas of focus include: Company creation, build out and financing Translation of technology into actionable and developable therapies Strategic Direction setting and optimisation of technology strengths Clinical Development planning and execution with the patient in mind Late stage development, commercialisation preparation and launch effectiveness Post-Marketing Patient-centric Medical and Clinical strategic support -
Steering Committee ChairUcl Sep 2019 - PresentLondon, Greater London, Gbhttps://www.ucl.ac.uk/biochemical-engineering/study/postgraduate-taught/manufacture-and-commercialisation-stem-cell-and-gene-therapies-mscChairman of Steering Committee for UCL Masters Programme in "Manufacture and Commercialisation of Stem Cell and Gene Therapies" -
Chair - Cell & Gene Therapy Advisory CommitteeBioindustry Association Jun 2016 - PresentLondon, GbEstablished over 25 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative life sciences in the UK. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives.Our members include: Start-ups, biotechnology and innovative life science companies Pharmaceutical and technological companies Universities, research centres, tech transfer offices, incubators and accelerators A wide range of life science service providers: investors, lawyers, IP consultants, IR agenciesWe promote an ecosystem that enables innovative life science companies to start and grow successfully and sustainably, and we do this through Influence, Connect, Save: -
Member Of The Scientific Advisory BoardLgc Group Sep 2019 - PresentWe are a global leader in the life sciences sector, serving customers in healthcare, applied markets (including food, agbio and the environment), research and government.We provide a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, research and measurement services. Our scientific tools and solutions form an essential part of our customers’ quality and compliance procedures enabling them to provide safer products, develop new solutions and advance research.Through a collaborative and consultative approach, our products and technology platforms help our customers bring new therapies to market; optimise food safety and production; enable diagnoses to be made more accurately; and support progressing product discovery through to manufacture with quality and consistency. In this way, we play our part in addressing important global drivers such as a growing and ageing population, globalisation and rise of emerging markets.LGC. Science for a safer world.
-
Chief Executive OfficerAntion Biosciences Sa Nov 2020 - Jul 2023Plan-Les-Ouates, Canton Of Geneva, ChAntion Biosciences SA is a Swiss biopharmaceutical company developing novel allogeneic gene and cell-based therapies to treat and cure diseases with significant unmet medical needs. Our proprietary cell engineering technologies allow for the creation of multimodal treatments that substantially enhance clinical safety and efficacy. Our patent-protected technologies are versatile, highly effective and applicable to various therapeutic areas. We believe that these technologies will enable us to create both first-in-class and best-in-class therapies. We recognize that strengthening our IP portfolio is central to the commercial success of Antion, and strive to enhance and protect our core technologies further. We actively explore collaborations and partnering opportunities to out-license our proprietary technologies and in-license novel technologies that are commercially important to us. -
Member Of The BoardXintela Ab Sep 2014 - May 2022Lund, Skåne, Se -
Member Of Executive BoardStandards Coordinating Body (Scb) Jul 2016 - Jul 2020Gaithersburg, Md, UsThe Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) brings together product developers, tools and service providers, professional societies, government entities, and academic centers with the intent to support standards development. Through the support, coordination, and education about the standards landscape and "gaps" associated with it in the regenerative medicine community, the SCB's goal is to create a more harmonized compliance environment and address/assist in future efforts (both domestically and internationally).SCB's mission is to efficiently and effectively support and improve the cost, time, and resources for regenerative product development.Find out more about the SCB organization, our methods, and the results of our coordinated efforts at https://www.standardscoordinatingbody.org/ -
Vp And Head Of Cell & Gene Therapy DevelopmentGsk May 2015 - Aug 2018Brentford, Middlesex, GbResponsible for the integrated development of a portfolio of ex-vivo stem cell gene therapies from pre-clinical POC to post-launch support and LCM. Leading the strategy for R&D, Clinical Operations, Regulatory, Safety and Medical Affairs for the vertically integrated structure within the division, acting as a small biotech within the larger company structure.Representing the Medical voice of Cell & Gene Therapy into R&D, commercial and importantly externally with the Rare Disease, Cell and Gene Therapy and Immunodeficiency communities. Representing the patients in the development and lisencing of breakthrough gene therapy technologies and with them in mind leading the way in expanding use to cover a greater geographical area. -
Senior Director, Global Medical Affairs - Cell Therapy & Regenerative MedicineGenzyme Biosurgery Dec 2011 - Apr 2015Paris, France, FrGlobal Medical Affairs responsibility for teams covering US, EU, Asia-Pacific and Australia.Responsibility for approval of global and regional promotional materialsStrategic and tactical global co-ordination and development of all publication and scientific presentationsGlobal lead for development and execution of all Investigator run clinical studiesDevelopment and maintenance of Global Key Opinion LeadersGlobal lead for all Medical Affairs activities in both pre-launch and post-launch activities.Medical Affairs lead for various international promotional and educational meetings - Advisory Boards, Advanced User meetingsMedical Affairs representation on various internal global leadership groupsMedical affairs lead for preparation of product Registration applications.Clinical input into Business Development activities and aquisitions.Co-ordination and training of network of Human Tissue licenced hospitals -
Senior Associate Medical Director - Renal, Cv And BiosurgeryGenzyme Therapeutics Jan 2011 - Dec 2011
-
Medical Director - MaciGenzyme Biosurgery Sep 2009 - Dec 2010Paris, France, FrGlobal Medical Affairs responsibility, covering UK, EU, Asia-Pacific and Australia.Responsibility for approval of global and EU promotional materialsStrategic and tactical global co-ordination and development of all publication and scientific presentationsGlobal lead for development and execution of all non-US Investigator run clinical studiesDevelopment and maintenance of Global Key Opinion LeadersGlobal Medical Affairs lead for all non-US countries, both post-launch and in developing a launch strategyMedical Affairs lead for various international promotional and educational meetings - Advisory Boards, Advanced User meetingsMedical Affairs representation on various internal global leadership groupsMedical affairs lead for preparation of Marketing application, Paediatric Investigation Plan & RMPCo-ordination and training of network of HTA licenced hospitals
-
Associate Medical DirectorGenzyme Biosurgery May 2008 - Oct 2009Paris, France, Fr
-
Senior Medical AdvisorGeistlich Biomaterials Oct 2004 - May 2008
-
Trauma & Orthopaedics Specialist RegistrarNhs Jan 2001 - Oct 2004GbHigher Surgical Trainee in Orthopaedics and Trauma Surgery. Specific experience gained in Lower Limb conditions ranging from Soft tissue pathologies to arthroplasty. I developed a special interest in Young arthroplasty and Orthobiologics. -
Basic Surgical TraineeNhs Feb 1997 - Dec 2000GbExperience gained in most facets of Clinical Surgical care, including Orthopaedics, Accident and Emergency Medicine, Urology, General Surgery (GI, Vascular and breast), Neurosurgery, Plastic Surgery.
-
Dive Instructor & Boat CaptainDon Fosters Dive, Cayman Feb 1987 - Oct 1989Taught all levels of recreational SCUBA diving in a Carribean resort setting. Captained a 54 foot dive boat.
-
Signals And Encryption OfficerSouth African Defense Force Jan 1985 - Dec 1986
Sven Kili Skills
Sven Kili Education Details
-
Royal College Of Surgeons Of EnglandSurgery -
Stellenbosch UniversityMedicine & Surgery
Frequently Asked Questions about Sven Kili
What company does Sven Kili work for?
Sven Kili works for Saisei Ventures
What is Sven Kili's role at the current company?
Sven Kili's current role is Partner.
What is Sven Kili's email address?
Sven Kili's email address is sv****@****gsk.com
What schools did Sven Kili attend?
Sven Kili attended Royal College Of Surgeons Of England, Stellenbosch University.
What skills is Sven Kili known for?
Sven Kili has skills like Clinical Trials, Clinical Research, Medical Affairs, Medical Devices, Biotechnology, Pharmaceutical Industry, Pharmacovigilance, Clinical Development, Medicine, Orthopedic, Surgery, Oncology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial